R THE INDIAN PHARMACIST Learn. Explore. Practise. Excel.
THE INDIAN PHARMACIST • ACADEMIC & CLINICAL REFERENCE PLATFORM Principal Reference: Indian Pharmacist Desk Reference — Edition 2.7 (2026–27)
THE INDIAN PHARMACIST — Learn. Explore. Practise. Excel. Official Logo

THE INDIAN PHARMACIST — Learn. Explore. Practise. Excel.

An open-access academic and clinical pharmacy knowledge platform for India's practising pharmacists, D.Pharm, B.Pharm and Pharm.D students, and GPAT & Drug Inspector aspirants—bringing together 519 structured medicine monographs, 51 curriculum chapters, 32 pharmacy calculators (13 clinical/PK simulators + 19 dose, paediatric, IV & compounding tools), 10-subject Exam Preparation Hub, Indian statutory schedules, and 64+ scientific visual diagrams.

519 REGISTRY / 270 MONOGRAPHS CHAPTERS 03–12

Complete 519 medicine monographs ([3.1]–[12.38]) with 4 clinical zones, Indian schedules, and transparent review-status disclosures.

51 ACADEMIC CHAPTERS 5 CORE DOMAINS

Structured Pharmacology, Pharmaceutics, Medicinal Chemistry, Pharmacognosy, and Hospital Pharmacy aligned with PCI syllabi.

32 PHARMACY CALCULATORS DETERMINISTIC

32 validated tools across 7 categories (13 clinical/PK workbench simulators + 19 dose, paediatric, IV drip, compounding & conversion calculators).

INDIAN LAW & VISUAL ATLAS 16 LAWS • 18 PLATES

Drugs & Cosmetics Act 1940, Schedules C–X, Pharmacy Act 1948, NPPA DPCO 2013, and 18 interactive clinical diagrams.

📌 Quick Access: Select any medicine or chapter to view recent items & saved bookmarks locally in your browser.

Structured Subject Discovery • Academic & Professional Pathways

Explore by Subject

Select any foundational discipline below to open its dedicated reference workspace or jump to its active tools.

PK LAB ACTIVE

1. Pharmacology

General pharmacology, dose-response receptor kinetics, autonomic & cardiovascular pharmacology, chemotherapy, and one-compartment clinical pharmacokinetics (Cmax, Tmax, AUC, t1/2).

Ch 02–12 & Atlas Plates
COMPENDIAL CORE

2. Pharmaceutical Sciences

Physical pharmaceutics, modified-release dosage form engineering (SR/ER/EC matrix rules), biopharmaceutics, medicinal chemistry SAR, pharmacognosy, and Indian Pharmacopoeia (IP) QA/QC standards.

IP Standards & Ch 20
ATLAS DIAGRAMS

3. Anatomy and Physiology

Organ-system physiology underlying drug action: renal nephron tubular transport (PCT, Loop of Henle, DCT, Collecting Duct), RAAS cascade, cardiac action potentials, and HPT endocrine feedback.

Atlas Plates I–V
ICMR AMSP

4. Microbiology

Bacterial cell-wall peptidoglycan (PBPs), 30S/50S ribosomal and DNA gyrase antimicrobial targets, moist/dry heat sterilization validation (F0 & D-value), endotoxin testing, and ICMR AWaRe stewardship.

Ch 08 & Sec 8.15
4 PREVIEW • 270 MAPPED

5. Medicine Knowledge

Structured 4-Zone, 12-Section generic medicine profiles covering indications, chronopharmacology, mechanism, KDIGO renal/hepatic adjustments, interactions, OPD counselling, and Schedule status.

Ch 03–12 (135 Paired Pages)
16 STATUTORY RECORDS

6. Indian Pharmacy and Regulations

Drugs and Cosmetics Act 1940, Drugs Rules 1945 (Schedules C, C1, G, H, H1, J, M, P, X & Forms 19–21B), Pharmacy Act 1948, PPR 2015, and DPCO 2013 essential medicine ceiling prices.

Ch 17 & Register D.7

Section 08 Flagship Tools • Deterministic Mathematical Engines

Pharmacy Calculator Workbench

Audited step-by-step clinical and compounding calculators with physiological boundary checks, unit conversions, and explicit safety notices.

21/21 CALCULATOR TESTS PASS EDUCATIONAL REFERENCE — DO NOT PRESCRIBE
TOOL A • RENAL PK VERIFIED

Creatinine Clearance (Cockcroft-Gault)

Adult CrCl (mL/min) using ABW, Devine IBW, or Obesity AdjBW (0.4 factor) with cm/in conversion.

TOOL B • COMPOUNDING VERIFIED

Alligation Alternate Calculator

Two-strength blending proportions, zero-concentration diluent support, and physical solute mass balance.

TOOL C • DISPENSING VERIFIED

Stock Dilution (C₁V₁ = C₂V₂)

Concentrated stock volume (V₁), cross-unit conversion (% w/v ↔ mg/mL), and diluent Q.S.

A. Adult Creatinine Clearance (Cockcroft & Gault, 1976)

ID: calc-cg-crcl

Section 03 Medicine Knowledge Library • Stage 2A 21-Section & 3-Audience Reference System

Searchable Generic Medicine Knowledge Library

Serving practising pharmacists, pharmacy students, and GPAT / Drug Inspector aspirants from one unified dataset. Features all 519 accessible medicine monographs ([3.1] through [12.38], plus separated [App-B.1] Emergency Adrenaline Module) across 10 canonical chapters and 22 therapeutic categories mapped to Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27).

Mandatory Educational & Review Governance Disclaimer: Educational reference material. Content awaiting independent clinical or regulatory review must not be treated as independently verified prescribing or legal guidance. (Review Status Breakdown: 28 Verified Baseline Educational • 241 Edition 2.7 Handbook-Source Awaiting Clinical Review • 1 Specialist Clinical Review Pending [[11.13] Phenytoin] • 222 Awaiting Independent Regulatory Schedule Verification).
Editorial & Clinical Content Governance Classification System (Schema v2.0 • 21 Standard Sections): Source Attribution + Independent Verification
1. HANDBOOK SOURCE CONTENT 2. VERIFIED EDUCATIONAL / REVIEWED 3. DEMONSTRATION DATA 4. AWAITING / PENDING CLINICAL REVIEW 5. AWAITING / PENDING REGULATORY REVIEW
Alphabetical Generic Index (A–Z Browsing):
Browse All 15 Therapeutic Categories (4 Active Pilot Categories • 11 Stage 2B Expansion Categories)

Section 10 Visual Learning Library • Precision Scientific Vector Diagrams

Oral One-Compartment Pharmacokinetic Concentration-Time Profile

Click or press Enter on any parameter hotspot (Cmax, Tmax, AUC, t1/2, or Therapeutic Window) to inspect its governing equation and exam significance.

Pharmacokinetic Plasma Drug Concentration vs. Time Curve Interactive one-compartment extravascular pharmacokinetic graph illustrating Cmax at 14.80 mg/L, Tmax at 1.88 hours, shaded AUC0-inf, elimination half-life t1/2 of 4.00 hours, Minimum Effective Concentration (4.0 mg/L), and Minimum Toxic Concentration (18.0 mg/L). Cmax = 14.8 mg/L (dCp/dt = 0) 0h 2h 4h 6h 8h 10h 12h Time Post Oral Administration (Hours) 0 4 8 12 15 18 Plasma Conc. Cp (mg/L) 1 2 3 4 5

PATHWAY A • STATUTORY REFERENCE Primary Legal & Licensing Reference (Distinguished from Pathway B: Competitive Exam Practice below)

Section 07 Jurisprudence Explorer • Statutory Law vs. Institutional Policy

Indian Pharmacy & Statutory Regulations Explorer

Search and filter 16 verified records from the Drugs and Cosmetics Act 1940, Drugs Rules 1945 (Schedules C, C1, G, H, H1, J, M, P, X & Forms 19–21B), Pharmacy Act 1948, PPR 2015, and DPCO 2013.

PATHWAY B • COMPETITIVE EXAM PREPARATION Active Recall, Option-by-Option Statutory Rationale & Exam Syllabus Mapping

Section 09 Competitive Examination Preparation Hub

Drug Inspector, GPAT & Government Pharmacist Exam Readiness

High-yield statutory & pharmacological question bank with option-by-option verification rationales and browser-local progress storage.

VERIFIED_EDUCATIONAL QUESTION
FEATURED HIGH-YIELD MCQ • ID: mcq-di-gpat-001

A retail community pharmacy licensed in Forms 20 and 21 dispenses Cefixime tablets (a drug specified in Schedule H1 of the Drugs Rules, 1945) against the prescription of a Registered Medical Practitioner. Under Rule 65 and Rule 97 of the Drugs Rules, 1945, which of the following combination of statutory requirements is MANDATORY for this supply?

Indian Competitive Pharmacy Exam Blueprint Matrix

SYLLABUS MAP

Our curriculum modules map directly to the core subject weightages tested in UPSC / State PSC Drug Inspector exams, GPAT, and AIIMS / ESIC / RRB / CGHS Pharmacist recruitments:

Examination Stream Primary High-Weightage Domains Linked Platform Tool
UPSC & State PSC Drug Inspector Drugs & Cosmetics Act 1940, Schedules C/G/H/H1/M/X, Forms 19–21B, Pharmacology, QA/QC Section 07 Explorer
GPAT (Graduate Pharmacy Aptitude Test) Biopharmaceutics & PK (Cmax, Tmax, AUC, t1/2), Alligation/Dilution, Pharmacology, Med Chem Section 08 & 10 PK
AIIMS / ESIC / RRB / CGHS Pharmacist Dispensing Pharmacy, Posology & Renal Dosing Principles, Hospital Pharmacy, Drug Store Laws Section 08 Workbench

Stage 5 Exam Engine Expansion Notice:

Stage 1.5 provides the verified single-question rationale engine and browser-local progress storage. Full topic-wise timed practice sets are scheduled for Stage 5.

Sections 01, 11 & Handbook Chapters 01, 13, 16, 20

Pharmacy Practice Protocols & Printable Reference Resources

Evidence-based OPD dispensing workflows, oral modified-release safety rules, and print-ready study handouts.

Resource Series Authored & Directed by THE INDIAN PHARMACIST Editorial Reference • Indian Pharmacist Desk Reference Ed. 2.7 (2026–27) • Release v2.7.4

HANDBOOK CH 01 • PAGE 11 HANDBOOK SOURCE

7-Step OPD Prescription Screening

  1. 1. Patient Identity & Age/Weight: Verify adult vs paediatric/geriatric status.
  2. 2. Diagnosis & Indication Match: Confirm therapeutic appropriateness.
  3. 3. Generic Name & LASA Check: Apply Tall-Man lettering verification.
  4. 4. Strength, Release Profile & Dose: Distinguish IR vs SR/XR/PR/EC.
  5. 5. Organ Function & Interactions: Screen eGFR/CrCl and CYP/P-gp pairs.
  6. 6. Chronotherapy & Food Relation: Label pre-meal vs with-meal timing.
  7. 7. Teach-Back Counselling: Confirm patient comprehension at counter.
HANDBOOK CH 20 • PAGE 209 MEDICATION SAFETY

Oral 'Do-Not-Crush' Formulation Rules

  • Enteric-Coated (EC / DR): Pantoprazole, Esomeprazole, Rabeprazole, Bisacodyl, Enteric Aspirin (acid labile or gastric irritant — never crush).
  • Sustained / Prolonged Release (SR / XR / PR): Metformin SR ([4.1]), Nifedipine SR, Diltiazem CD, Sodium Valproate CR (crushing causes fatal dose dumping).
  • Cytotoxic / Teratogenic Tablets: Methotrexate, Finasteride, Dutasteride, Mycophenolate (powder aerosolization/skin hazard).
  • Sublingual / Orally Disintegrating: Nitroglycerin SL, Ondansetron MD (engineered for rapid mucosal absorption).
APPENDIX A.2 • PAGE 213 HANDBOOK SOURCE

'SAD-MANS' Acute Sick-Day Protocol

Counsel patients to seek medical review regarding temporary medication pause during acute dehydrating illness (severe vomiting/diarrhoea/fever):

  • S — Sulfonylureas (Glimepiride, Gliclazide: hypoglycaemia)
  • A — ACE Inhibitors (Ramipril, Enalapril: acute kidney injury)
  • D — Diuretics (Furosemide, Thiazides, Spironolactone)
  • M — Metformin ([4.1]: lactic acidosis risk in AKI)
  • A — ARBs (Telmisartan, Losartan: efferent constriction)
  • N — NSAIDs (Diclofenac, Ibuprofen: afferent constriction)
  • S — SGLT2 Inhibitors (Dapagliflozin: euglycaemic DKA)

Print-Ready Study Sheets & Stage 1.5 Reference Packages

Use your browser's Print command (Ctrl+P) on any internal reference page to generate clean A4 study sheets via our built-in @media print stylesheet.

Complete 12-Section Platform Architecture • Governance & Syllabus Map

Twelve Academic & Professional Curriculum Pillars

Filter by curriculum division or inspect any pillar's sub-modules, verification status, and official statutory citations.

OFFICIAL PUBLISHING DIVISION • THE INDIAN PHARMACIST FREE PUBLIC EDUCATIONAL RELEASE — BOOKSTORE CATALOGUE PREVIEW
Founder, Creator & Principal Author: THE INDIAN PHARMACIST Editorial Reference

Official Publications — Purchase Facility Coming Soon

Explore the official publication catalogue authored by THE INDIAN PHARMACIST Editorial Reference, featuring the flagship Indian Pharmacist Desk Reference — Professional Edition 2.7 (2026–27) and forthcoming professional pharmacy reference compendia. Direct online ordering for Printed (Hardcover & Paperback) and Digital PDF editions will open upon completion of merchant onboarding.

100% Free Educational Access: All 519 Medicine Monographs, 51 Academic Chapters, 13 Clinical Calculators, 3D/2D Visual Atlas & 67 Exam MCQs are permanently free to read and use on this platform.
Public Release Status
Release Classification: v3.1.1 PUBLIC LAUNCH
Educational Platform: 100% FREE ACCESS
Bookstore Catalogue: PREVIEW ONLY
Purchase Facility: COMING SOON
BOOKSTORE CATALOGUE PREVIEW MODE

Official Publications — Purchase Facility Coming Soon

Online checkout, payment collection, and digital downloads are currently disabled in this public educational release while merchant onboarding is finalised.

CHECKOUT DISABLED
Official Author Catalogue • Verified Specifications & Genuine Covers

Publications by THE INDIAN PHARMACIST Editorial Reference

Official publication specifications and format editions (Printed & Digital PDF). Online ordering coming soon.

Scalable Catalogue Pipeline • Future Releases

Forthcoming Educational & Competitive Examination Publications

IN EDITORIAL PREPARATION
Publishing & Reader Governance

Terms, Privacy, Fulfilment Overview, Digital Licence & Educational Disclaimer

Official Reader & Platform Governance
FOUNDER & CREATOR IDENTITY • PLATFORM OVERVIEW

About THE INDIAN PHARMACIST & Founder Identity

Tejas Chandrakant Nartam (Tejas Nartam) — Founder & Creator of THE INDIAN PHARMACIST
Full Name: Tejas Chandrakant Nartam
Display Name: Tejas Nartam
Designation: Founder & Creator — THE INDIAN PHARMACIST

Tejas Chandrakant Nartam (Tejas Nartam), Founder & Creator of THE INDIAN PHARMACIST, created this educational pharmacy platform to provide students, pharmacists, and educators with structured medicine monographs, clinical calculators, visual pharmacology diagrams, and regulatory resources. Visit the standalone About / Creator Page →